Thromboxane synthetase inhibition reduces ventricular irritability after coronary occlusion and reperfusion
- 2 March 1988
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 115 (3) , 505-509
- https://doi.org/10.1016/0002-8703(88)90797-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusionAmerican Heart Journal, 1986
- Augmented thromboxane A2 generation and efficacy of its blockade in acute myocardial infarctionInternational Journal of Cardiology, 1985
- Thromboxane A2 in acute myocardial infarctionAmerican Heart Journal, 1984
- Determinants of Cardiovascular Stability During Abdominal Aortic Aneurysmectomy (AAA)Annals of Surgery, 1984
- Results in 339 patientsThe Journal of Thoracic and Cardiovascular Surgery, 1983
- Effect of coronary reperfusion on myocardial hemorrhage and infarct healingThe American Journal of Cardiology, 1983
- A Randomized Trial of Intracoronary Streptokinase in the Treatment of Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Circulation, 1977
- Deleterious effects due to hemorrhage after myocardial reperfusionThe American Journal of Cardiology, 1974
- Coronary Artery ReperfusionJournal of Clinical Investigation, 1972